Thymoglobulin and Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplantation: 1-Year Results of a Prospective Clinical Trial

被引:0
|
作者
Favi, E. [1 ]
Silvestrini, N. [1 ]
Spagnoletti, G. [1 ]
Castagneto, M. [1 ]
Citterio, F. [1 ]
机构
[1] Catholic Univ, Rome, Italy
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
388
引用
收藏
页码:147 / 147
页数:1
相关论文
共 50 条
  • [1] Thymoglobulin Plus Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplant Recipients Treated with Tacrolimus and Mycophenolate Mofetil: 1-Year Results of a Prospective Clinical Trial.
    Favi, E.
    Spagnoletti, G.
    Silvestrini, N.
    Salerno, M.
    Pedroso, J.
    Romagnoli, J.
    Citterio, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 426 - 426
  • [2] THYMOGLOBULIN PLUS BASILIXIMAB VERSUS BASILIXIMAB INDUCTION IN DECEASED DONOR KIDNEY TRANSPLANT RECIPIENTS TREATED WITH TACROLIMUS AND MMF: 1-YEAR RESULTS OF A PROSPECTIVE CLINICAL TRIAL
    Favi, Evaldo
    Spagnoletti, Gionata
    Silvestrini, Nicola
    Salerno, Maria P.
    Pedroso, Jose A.
    Romagnoli, Jacopo
    Citterio, Franco
    TRANSPLANT INTERNATIONAL, 2013, 26 : 83 - 83
  • [3] Induction with Thymoglobulin Plus Basiliximab Is Safe and Effective in Expanded Criteria Donor Kidney Transplant Recipients: 1-Year Results of a Prospective Clinical Trial.
    Favi, E.
    Silvestrini, N.
    Romagnoli, J.
    Salerno, M. P.
    Pedroso, J. A.
    Citterio, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 318 - 319
  • [4] Lower Acute Rejection with Basiliximab and Short Course, Low Dose Thymoglobulin vs Basiliximab as Induction Therapy in Deceased Donor Renal Transplant Recipients: 6-Month Results of a Prospective Clinical Trial
    Favi, Evaldo
    Silvestrini, Nicola
    Valente, Iacopo
    Salerno, Maria Paola
    Castagneto, Marco
    Citterio, Franco
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 321 - 321
  • [5] Thymoglobulin Versus Basiliximab Induction Therapy for Kidney Transplant From Deceased Donor With Acute Kidney Injury
    Jung, C.
    Jun, H.
    Kim, M.
    Park, K.
    Kim, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 583 - 583
  • [6] THYMOGLOBULIN VERSUS BASILIXIMAB INDUCTION THERAPY FOR KIDNEY TRANSPLANT FROM DECEASED DONOR WITH ACUTE KIDNEY INJURY
    Park, Kwantae
    Otgonbayar, Adiyakhuu
    TRANSPLANT INTERNATIONAL, 2017, 30 : 472 - 472
  • [7] Thymoglobulin Versus Basiliximab Induction Therapy for Kidney Transplant From Deceased Donor With Acute Kidney Injury.
    Jung, C.
    Jun, H.
    Kim, M.
    Park, K.
    Kim, S.
    TRANSPLANTATION, 2014, 98 : 583 - 583
  • [8] Induction Therapy in Simultaneous Pancreas-Kidney Transplantation: Thymoglobulin Versus Basiliximab
    Fernandez-Burgos, I.
    Montiel Casado, M. C.
    Perez-Daga, J. A.
    Aranda-Narvaez, J. M.
    Sanchez-Parez, B.
    Leon-Diaz, F. J.
    Cabello-Diaz, M.
    Rodriguez-Burgos, D.
    Hernandez-Marrero, D.
    Santoyo-Santoyo, J.
    TRANSPLANTATION PROCEEDINGS, 2015, 47 (01) : 120 - 122
  • [9] Late Calcineurin Inhibitors Introduction after Induction with Basiliximab and Thymoglobulin Is Safe and Effective in Old for Old Renal Transplantation: 1-Year Results of a Prospective Clinical Study.
    Favi, E.
    Silvestrini, N.
    Spagnoletti, G.
    Romagnoli, J.
    Castagneto, M.
    Citterio, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 254 - 254
  • [10] Results of induction therapy with Basiliximab in lung transplantation
    De la Torre, Mercedes
    Borro, Jose M.
    Gonzalez, Diego
    Fernandez, Ricardo
    Delgado, Maria
    TRANSPLANT INTERNATIONAL, 2007, 20 : 304 - 304